Stoneridge Investment Partners’s Endologix Inc ELGX Stock Holding History

Stoneridge Investment Partners’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,994	Closed	-$134K	–	284
2017 Q3	$134K	Sell	2,994 -780	-21%	-$35.5K	0.02%	225
2017 Q2	$183K	Sell	3,774 -15,860	-81%	-$934K	0.03%	230
2017 Q1	$1.42M	Buy	19,634 +11,533	+142%	+$763K	0.19%	152
2016 Q4	$463K	Buy	8,101 +6,083	+301%	+$557K	0.06%	227
2016 Q3	$258K	Sell	2,018 -9	-0.4%	-$1.15K	0.04%	241
2016 Q2	$253K	Sell	2,027 -4,888	-71%	-$562K	0.04%	241
2016 Q1	$578K	Sell	6,915 -7,526	-52%	-$620K	0.08%	195
2015 Q4	$1.43M	Buy	+14,441	New	+$1.55M	0.19%	134

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Stoneridge Investment Partners's ELGX Position: Q4 2017 in Review

Stoneridge Investment Partners sold out of Endologix Inc (ELGX) in Q4 2017, closing a stake of 2,994 shares — an estimated $134K sold.

Stoneridge Investment Partners first reported a position in ELGX in Q4 2015 and held it in 8 quarters. The position peaked at $1.43M in Q4 2015. 103 funds tracked by Wall St. Rank hold ELGX as of Q4 2017.

Stoneridge Investment Partners reported no remaining Endologix Inc position as of Q4 2017 after selling out during the quarter.
Stoneridge Investment Partners sold 2,994 Endologix Inc shares in Q4 2017, an estimated $134K.
Stoneridge Investment Partners first reported a position in Endologix Inc in Q4 2015 and held it in 8 quarters.
Stoneridge Investment Partners's Endologix Inc position peaked at $1.43M in Q4 2015.
103 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2017.

Based on Stoneridge Investment Partners's 13F filing for Q4 2017, filed 5 Feb 2018.